Australia (Jurisdiction Profile)
Jurisdiction Identity
| Field | Value |
|---|---|
| Country | Australia |
| ISO country code | AU |
| National authorities | Therapeutic Goods Administration (TGA); Office of Drug Control (ODC); state/territory health departments |
| Official sources | https://www.tga.gov.au/resources/explore-topic/medicinal-cannabis-hub ; https://www.odc.gov.au/medicinal-cannabis |
| Last verified | 2026-08-09 |
Cannabis Framework
| Dimension | Status |
|---|---|
| Adult-use possession | Prohibited federally; ACT allows limited personal use (up to 50 g; 2 plants per person, 4 per household); WA personal-use bill introduced 2026 (not enacted) |
| Adult-use cultivation | Prohibited federally (no personal cultivation support under the Act) |
| Adult-use commercial supply | Not legal |
| Medical access | Medicinal cannabis available by prescription via Special Access Scheme (SAS) and Authorised Prescriber (AP) pathways |
| Pharmaceutical cannabinoid access | TGA-regulated products (some registered; most accessed as unapproved products via SAS/AP) |
| Home cultivation | Prohibited federally (ACT personal-use exception) |
| Import/export | Import regulated by TGA (SAS/AP); cultivation/manufacture licensed by the ODC |
Subnational Systems
Cannabis law is a state/territory matter for personal use, while medicinal cannabis is nationally regulated (TGA/ODC). Only the Australian Capital Territory has enacted a personal-use exemption; Western Australia’s 2026 Misuse of Drugs Amendment (Lawful Personal Use of Cannabis) Bill was introduced but not enacted as of retrieval. Deeper subnational modeling is warranted for possession law variance.
Regulatory Overview
Australia regulates medicinal cannabis nationally: the TGA oversees product access (SAS/AP pathways; a 2025 TGA inquiry reviewed unapproved-product use), and the Office of Drug Control licenses cultivation and manufacture under the Narcotic Drugs Act. GMP is required for commercial production; analytical testing labs must meet NATA/ISO 17025 standards. Adult use remains illegal federally.
Licensing Structure
- ODC licences/permits: cultivation, production, research (Narcotic Drugs Act 1967); GMP compliance required.
- TGA access: SAS Category B and Authorised Prescriber schemes for patients.
Laboratory / Quality Framework
- Products must meet TGA quality standards (GMP manufacturing; analytical testing to pharmacopoeial methods; ISO 17025 labs).
- No public per-batch COA database; adverse-event reporting flows to the TGA (27 voluntary cases reported in 2026 through July).
Data Surface
| Data surface | Available? | Official source | Machine-readable? | Notes |
|---|---|---|---|---|
| License registry | partial | ODC licensed cultivators/manufacturers | no | Published information; no API located |
| Testing-laboratory registry | partial | NATA-accredited lab directories | partial | NATA directory (generic, not cannabis-specific) |
| Laboratory testing rules | yes | TGA guidance + pharmacopoeial standards | no | Codified requirements |
| Contaminant/action limits | yes | TGA quality standards | no | Set in standards |
| Recalls/advisories | partial | TGA medicine recalls/alerts | yes | TGA recalls database is searchable |
| Product/package identifiers | partial | TGA ARTG (registered products) | yes | ARTG is a searchable register |
| COAs/batch results | no public source located | — | — | Not public |
| Sales data | partial | TGA/industry statistics | partial | Aggregate access statistics |
| Open-data downloads | partial | TGA ARTG data | partial | Register searchable; bulk formats limited |
Future Ingestion Opportunities
- TGA ARTG medicinal-cannabis entries → product/reference records.
- TGA recalls/alerts → recall entities.
- ODC licensing stats → aggregate records.
- Monitor ACT personal-use framework and the WA bill — state-level divergence is an active policy area.
Sources & Provenance
- Statutory framework: Narcotic Drugs Act 1967; Therapeutic Goods Act 1989; ACT Drugs of Dependence (Personal Cannabis Use) Amendment Act 2019 (effective January 2020).
- TGA hub: https://www.tga.gov.au/resources/explore-topic/medicinal-cannabis-hub
- ODC: https://www.odc.gov.au/medicinal-cannabis
- Retrieval date: 2026-08-09
Graph Connections
No existing repository entities are linked to Australia. The page is discoverable from the Jurisdictions index.